期刊文献+

胃肠间质瘤38例诊治分析 被引量:1

The diagnosis and treatment of gastrointestinal stromal tumor-analysis of 38 cases
下载PDF
导出
摘要 目的:探讨胃肠间质瘤(GIST)的诊断及治疗方法。方法:X线钡剂检查16例,小肠造影3例,内窥镜检查35例,B超检查38例,CT检查37例。37例GIST行手术切除,1例GIST术中活检,所有病例均经病理证实。结果:手术切除率97.37%,3例胃部GIST患者分别于术后5、9、11个月死于肿瘤转移,5例胃部GIST患者分别于术后4、7、10、11、12个月出现肝转移。30例病人随访至今仍无瘤生存。结论:目前GIST的治疗以手术与药物综合治疗为主,胃部GIST发生转移的机会大于其它部位的GIST,转移的脏器多位于肝脏。 Objective: To evaluate the diagnosis and treatment of gastrointestinal stromal tumor (GIST). Methods: Among 38 patients, all cases undergone ultrasound, 16 barium study, 35 endoscopies,37 CT. 37 cases were treated by operation, 1 case accepted biopsy during surgery. All of them were proved by pathology and after follow-up of 2 to 54 months. Results: 97.37% was resectable during operation. 3 cases were died because of metastases 5, 9, 7 months after operation. 5 cases developed metastases 4, 7, 10,11,12 months after operation. Still 30 cases alive without tumor. Conclusions: The chief remedy of GIST is operation and drug therapy, gastro stromal tumors have more likelihood of developing metastases, and metastases usually locates on liver.
出处 《新疆医科大学学报》 CAS 2006年第9期860-861,共2页 Journal of Xinjiang Medical University
基金 新疆维吾尔自治区高校科研计划重点项目(XJEDU2004134)
关键词 胃肠间质瘤 诊断 治疗 gastrointestinal stromal tumors (GIST) diagnosis treatment
  • 相关文献

参考文献6

二级参考文献51

  • 1王吉甫.胃平滑肌瘤与平滑肌肉瘤[J].中国实用外科杂志,1995,15(8):491-493. 被引量:24
  • 2DeiTos AP.The reappraisal of gastrointestinal stromal tumors:From Stout to the KIT revolution[J].Virchows Arch,2003,442:421-428.
  • 3Fletcher CD, Berman JJ, Corless C,et al.Diagnosis of gastrointestinal stromal tumors:A consensus approach[J].Hum Pathol,2002,33:459-465.
  • 4Singer S,Rubin BP,Lux ML,et al.Prognostic value of KIT mutation type,mitotic activity, and histologic subtype in gastrointestinal stromal tumors[J].J Clin Oncol,2002,20:3898-3905.
  • 5Wong NA,Young R,Malcomson RD,et al.Prognostic indicators for gastrointestinal stromal tumours: A clinicopathological and immunohistochemical study of 108 resected cases of the stomach[J].Histopathology,2003,43:118-126.
  • 6Medina-Franco H,Ramos-DelaMedina A,Cortes-Gonzalez R,et al.Expression of p53 and proliferative index as prognostic factors in gastrointestinal sarcomas[J].Ann Surg Oncol,2003,10:190-195.
  • 7Takahashi R,Tanaka S,Kitadai Y,et al.Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach[J].Oncology,2003,64:266-274.
  • 8Roberts PJ,Eisenberg B.Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease[J].Eur J Cancer,2002,38(suppl 5):S37-S38.
  • 9Bumming P,Andersson J,Meis-Kindblom JM,et al.Neoadjuvant,adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib:A centre-based study of 17 patients[J].Br J Cancer,2003,89:460-464.
  • 10Samiian L,Weaver M,Velanovich V.Evaluation of gastrointestinal stromal tumors for recurrence rates and patterns of long-term follow-up[J].The American Surgeon,2004,70(3):187-192.

共引文献22

同被引文献17

  • 1揭志刚,谢小平,秦克旺,刘逸,李正荣,戴安邦,姚育修.胃肠道间质瘤预后因素的临床分析[J].中华胃肠外科杂志,2005,8(3):210-212. 被引量:24
  • 2邓志刚,李波,李敬东,严茂林,栗靖,霍永忠.胃肠道间质瘤136例诊治及预后分析[J].腹部外科,2006,19(1):34-36. 被引量:5
  • 3Parfitt JR, Streutker C J, Riddell RH, et a. 1 Gastrointestina, 1 stromal tumors: a contemporary review [J]. Pathol Res Pract,2006,202(12) :837 -847.
  • 4Trupiano JK, Stewart RE, MisickC, et al. Gastric stromal tumors:a clinicopathologic study of 77 cases with correlation of features with nonaggressive and aggressive clinical behaviors. Am J Surg Pathol, 2002,26:705-714.
  • 5Rant CP, Morgan JA, Ashley SW. Cunrrent issues ingastroin testinal stromal tumors: incidence, molecular biology, and contemporary treatment of localized and advanced disese[ J]. Curr Opin Gastroentero, 1 2007,23(2) : 149-158.
  • 6Joensuu H, Fletcher C, Dimitrijevic S, et al. Management of malignant gastrointestinal stromal tumors [ J ]. Lancet on - col, 2002,3 ( 11 ) : 655- 664.
  • 7Hohenberger P, Langer C, Pistorius S, et al. Indication and results of Surgery following imatinib treatment of locally advanced or metastatic GI stromal tumors (GIST). J Clin Oncol, 2006 ASCO Annual Meeting Proceedings Part I. 2006,24 (18S) : 9500.
  • 8Mussi C, Ronel len fitschu, Jakob J, et al. posl imatinib surgery in advanced/metastatic GIST: is it worthw h ile in all paitents? Annals of onclogy, 2009,10 : 1093.
  • 9Eisenberg BL, Harris J, Blanke CD, et al. Phase Ⅱ trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced prim ary and metastatic/recurrent operable gastrointestinal strom al tumor(GIST) :early results ofRTOGO132/ACRIN6665. J Surg Onco, 12009,99( 1 ) :42-47.
  • 10Heinrich MC, Maki RG, Corless CL, et al. Sunitinib(SU) response in imatinib - resistant ( IM -R) GIST correlates with KIT and PDGPFA mutation status. J Clin Oncol,2006ASCO Annum Meeting Proceedings Patti. 2006,24(18S) :9502.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部